News

Former LigoCyte Pharmaceuticals research facility in Bozeman set to close within two years

akeda Pharmaceutical Company announced earlier this month plans to close its vaccine facility in Bozeman as part of a company-wide consolidation over the next two years.

The Bozeman facility, formerly LigoCyte Pharmaceuticals at 2155 Analysis Drive, is home to labs, business offices and some manufacturing, according to Don Beeman, former CEO of LigoCyte.

By Daniel DeMay Chronicle Staff Writer

Full Story: http://www.bozemandailychronicle.com/news/economy/research-facility-in-bozeman-set-to-close-within-two-years/article_31366de3-f497-5f2a-b968-988f2a9fd1a3.html

Related Stories

Leave a Comment

You must be logged in to post a comment.